Vanberra Signal
Free trial

Diagnostics.ai

Curated by Signal

Developer of AI-based automated diagnostics platform

Life Sciences Technologydiagnostics.ai

Overview

Developer of AI-based automated diagnostics platform. Its patented technology is based on machine learning algorithms that self-calibrate by studying how an expert clinical technician interprets test results and then by applying derived knowledge to automate future routine analyses. Based on the technology, it has developed its product pcr.ai for automating and thereby standardizing qPCR test analysis.

Key facts

Founded
2009
Headquarters
Barnet, United Kingdom
Stage
Sign up to view
Industry
Life Sciences Technology

Business model

1 product or service
Sign up to view

Contact

Primary office
Sign up to view
Email
Sign up to view
Phone
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

  • Microplate Dx

    Developer of a diagnostic test for drug-resistant infections

    Life Sciences TechnologyGlasgow, United Kingdom

  • Rayner

    Portfolio of intracocular lenses and surgical tools for cataract surgery

    Life Sciences TechnologyBrighton, United Kingdom

  • Palmdoc

    Blood glucose monitoring system

    Life Sciences TechnologyPeterborough, United Kingdom

About Diagnostics.ai

What does Diagnostics.ai do?

Developer of AI-based automated diagnostics platform.

Where is Diagnostics.ai headquartered?

Diagnostics.ai is headquartered in Barnet, United Kingdom.

When was Diagnostics.ai founded?

Diagnostics.ai was founded in 2009.

Which sector is Diagnostics.ai in?

Diagnostics.ai operates in Life Sciences Technology.

Who are Diagnostics.ai's competitors?

Companies similar to Diagnostics.ai include Microplate Dx, Rayner, and Palmdoc.